γ-Tocotrienol inhibits cell viability through suppression of β-catenin/Tcf signaling in human colon carcinoma HT-29 cells

Journal of Nutritional Biochemistry

Volumn 23, Issue 7, 2012, Pages 800-807

  Xu, Weili ^a,b   Du, Ming ^a   Zhao, Yonghuan ^c   Wang, Qi ^b   Sun, Wenguang ^b   Chen, Bingqing ^b  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c HEILONGJIANG AUGUST FIRST LAND RECLAMATION UNIVERSITY   (China)

Author keywords

Catenin; Tocotrienol; Cancer chemoprevention; HT 29 cells; Wnt signaling

Indexed keywords

BETA CATENIN; CYCLIN D1; GAMMA TOCOTRIENOL; MYC PROTEIN; SMALL INTERFERING RNA; SURVIVIN; T CELL FACTOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL MEMBRANE; CELL STRUCTURE; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; ONCOGENE C MYC; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

APOPTOSIS; BETA CATENIN; CELL SURVIVAL; CHROMANS; COLON; COLONIC NEOPLASMS; CYCLIN D1; DOWN-REGULATION; HT29 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; PHOSPHORYLATION; PLANT EXTRACTS; PLANT OILS; TCF TRANSCRIPTION FACTORS; VITAMIN E; WNT SIGNALING PATHWAY;

EID: 84862315403     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.04.003     Document Type: Article

References (54)

1. Laurier J. WHO report: alarming increase in cancer rates Retrieved 21/02/2006, 2006, from. http://www.wsws.org/articles/2003/apr2003/canc-a26.shtml.
2. Increase in global cancer rates: the World Cancer Report. Oncol Forum 2003, 24.
3. Global Cancer Facts and Figures 2007. Available at: Accessed April 27, 2009. http://ww2.cancer.org/downloads/STT/Global_Facts_and_Figures_2007_rev2.pdf.
4. Osias G.L., Osias K.B., Srinivasan R. Colorectal cancer in women: an equal opportunity disease. J Am Osteopath Assoc 2001, 101:S7-12.
5. Polakis P. The oncogenic activation of beta-catenin. Curr Opin Genet Dev 1999, 9:15-21.
6. Waltzer L., Bienz M. The control of beta-catenin and TCF during embryonic development and cancer. Cancer Metastasis Rev 1999, 18:231-246.
7. Behrens J. Control of beta-catenin signaling in tumor development. Ann N Y Acad Sci 2000, 910:21-33.
8. Behrens J., vonKries J.P., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996, 382:638-642.
9. Molenaar M., van de Wetering M., Oosterwegel M., Peterson-Maduro J., Godsave S., Korinek V., et al. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 1996, 86:391-399.
10. Fevr T., Robine S., Louvard D., Huelsken J. Wnt/β-Catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol 2007, 27:7551-7559.
11. Sparks A.B., Morin P.J., Vogelstein B., Kinzler K.W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998, 58:1130-1134.
12. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997, 275:1787-1790.
13. Rafter J., Govers M., Martel P., Pannemans D., Pool-Zobel B., Rechkemmer G., et al. PASSCLAIM - diet-related cancer. Eur J Nutr 2004, 43:1147-1184.
14. Kim D.H., Ahn Y.O. Molecular epidemiology of colon cancer. Cancer Res Treat 2004, 36(2):93-99.
15. Swaroop V.S., Larson M.V. Colonoscopy as a screening test for colorectal cancer in average-risk individuals. Mayo Clin Proc 2002, 77:951-956.
16. Mucci L.A., Wedren S., Tamimi R.M., Trichopoulos D., Adami H.O. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med 2001, 249:477-493.
17. Greenberg E.R., Baron J.A., Tosteson T.D., Freeman D.H., Beck G.J., Bond J.H., et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 1994, 331(3):141-147.
18. Bostick R.M., Potter J.D., McKenzie D.R., Sellers T.A., Kushi L.H., Steinmetz K.A., et al. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res 1993, 53:4230-4237.
19. No authors listed The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994, 330:1029-1035.
20. Paganelli G.M., Biasco G., Brandi G., Santucci R., Gizzi G., Villani V., et al. Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas. J Natl Cancer Inst 1992, 84:47-51.
21. Mo H., Elson C.E. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J Nutr 1999, 129:804-813.
22. Nesaretnam K., Dorasamy S., Dabre D. Tocotrienol inhibit growth of ZR-75-1 breast cancer cells. Int J Food Sci Nutr 2000, 51:S95-105.
23. Stone W.L., Krishnan K., Campbell S.E., Qui M., Whaley S.G., Yang H. Tocopherols and the treatment of colon cancer. Ann N Y Acad Sci 2004, 1031:223-233.
24. Takahashi K., Loo G. Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells. Biochem Pharmacol 2004, 67:315-324.
25. Srivastava J.K., Gupta S. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun 2006, 346:447-453.
26. Sakai M., Okabe M., Tachibana H., Yamada K. Apoptosis induction by gamma-tocotrienol in human hepatoma Hep3B cells. J Nutr Biochem 2006, 17:672-676.
27. Xu W.L., Liu J.R., Liu H.K., Qi G.Y., Sun X.R., Sun W.G., et al. Inhibition of proliferation and induction of apoptosis by γ-tocotrienol in human colon carcinoma HT-29 cells. Nutrition 2009, 25:555-566.
28. Xu W.L., Wang Q., Du M., Zhao Y.H., Sun X.R., Sun W.G., et al. Growth inhibition effect of β-catenin-siRNA-mediated gene silencing on human colon carcinoma HT-29 cells. Cancer Biother Radiopharm 2010, 25(5):529-537.
29. Yu W., Simmons-Menchaca M., Gapor A., Sanders B.G., Kline K. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer 1999, 33(1):26-32.
30. Sylvester P.W., Birkenfeld H.P., Hosick H.L., Briski K.P. Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferation in vitro. Exp Cell Res 1994, 214:145-153.
31. McIntyre B.S., Birkenfeld H.P., Sylvester P.W. Relationship between epidermal growth factor receptor levels, autophosphorylation and mitogenic-responsiveness in normal mouse mammary epithelial cells in vitro. Cell Prolif 1995, 28:45-56.
32. McIntyre B.S., Briski K.P., Hosick H.L., Sylvester P.W. Effects of dependent mammary epithelial cell growth. Proc Soc Exp Biol Med 1998, 217:180-187.
33. Sylvester P.W., Nachnani A., Shah S., Briski K.P. Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac J Clin Nutr 2002, 11:S452-S459.
34. Gehrke I., Gandhirajan R.K., Kreuzer K.A. Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options. Eur J Cancer 2009, 45:2759-2767.
35. American Institute for Cancer Res earch Plant compounds continue to challenge science Available at. http://www.aicr.org/site/PageServer.
36. McIntyre B.S., Briski K.P., Gapor A., Sylvester P.W. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Pro Soc Exp Biol Med 2000, 224:292-301.
37. Sun W., Wang Q., Chen B., Liu J., Liu H., Xu W. Gamma-tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signalling. Br J Nutr 2008, 99:1247-1254.
38. Shah S., Gapor A., Sylvester P.W. Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells. Nutr Cancer 2003, 45:236-246.
39. Sylvester P.W., Shah S.J., Samant G.V. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of gamma-tocotrienol in neoplastic mammary epithelial cells. J Plant Physiol 2005, 162:803-810.
40. Polakis P. Wnt signaling and cancer. Genes Dev 2000, 14:1837-1851.
41. Zhurinsky J., Shtutman M., Ben-Ze'ev A. Plakoglobin and β-catenin: protein interactions, regulation and biological roles. J Cell Sci 2000, 113:3127-3139.
42. Park S., Gwak J., Cho M., Song T., Won J., Kim D.E., et al. Hexachlorophene inhibits Wnt/beta-catenin pathway by promoting Siah-mediated beta-catenin degradation. Mol Pharmacol 2006, 70:960-966.
43. Choi H., Gwak J., Cho M., Ryu M.J., Lee J.H., Kim S.K., et al. Murrayafoline A attenuates the Wnt/beta-catenin pathway by promoting the degradation of intracellular beta-catenin proteins. Biochem Biophys Res Commun 2010, 391:915-920.
44. Wang J.B., Qi L.L., Zheng S.D., Wang H.Z., Wu T.X. Curcumin suppresses PPARδ expression and related genes in HT-29 cells. World J Gastroenterol 2009, 15:1346-1352.
45. Roh H., Green D.W., Boswell C.B., Pippin J.A., Drebin J.A. Suppression of β-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Cancer Res 2001, 61:6563-6568.
46. Verma U.N., Surabhi R.M., Schmaltieg A., Becerra C., Gaynor R.B. Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 2003, 9:1291-1300.
47. Green D.W., Roh H., Pippin J.A., Drebin J.A. β-Catenin antisense treatment decreases β-catenin expression and tumor growth rate in colon carcinoma xenografts. J Surg Res 2001, 101:16-20.
48. Foley P.J., Scheri R.P., Smolock C.J., Pippin J., Green D.W., Drebin J.A. Targeted suppression of β-catenin blocks intestinal adenoma formation in APC Min mice. J Gastrointest Surg 2008, 12:1452-1458.
49. Sherr C.J. Cancer cell cycle. Science 1996, 274:1672-1677.
50. Thompson E.B. The many roles of c-Myc in apoptosis. Annu Rev Physiol 1998, 60:575-600.
51. Johnson M.E., Howerth E.W. Survivin: A bifunctional inhibitor of apoptosis protein. Vet Pathol 2004, 41:599-607.
52. Singh S., Aggarwal B.B. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J Biol Chem 1995, 270:24995-25000.
53. Mukhopadhyay A., Banerjee S., Stafford L.J., Xia C., Liu M., Aggarwal B.B. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 2002, 21:8852-8861.
54. Ryu M.J., Cho M., Song J.Y., Yun Y.S., Choi I.W., Kim D.E., et al. Natural derivatives of curcumin attenuate the Wnt/β-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun 2008, 377:1304-1308.